Stock listing

Kezar Life Sciences, Inc.

Selected listing: A40NJT · LSX · EUR · DE

Kezar Life Sciences, Inc. (LS Exchange: A40NJT), Health Technology. Latest release Mar 12, 2026: Enodia Therapeutics Strengthens Sec61 Portfolio Through…

A40NJT:LSXEURDEUpdated September 22, 2026

Ticker: LS Exchange: A40NJT
Asset type: Stock
Sector: Health Technology
Industry: Biotechnology
Exchange: LS Exchange
Currency: EUR

Latest news from Kezar Life Sciences, Inc.

Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences

March 12, 2026

Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis

January 9, 2026

Kezar Life Sciences Reports Third Quarter 2025 Financial Results

November 12, 2025

Kezar Life Sciences Announces Presentation of PORTOLA Data at the American Association for the Study of Liver Disease (AASLD) – The Liver Meeting® 2025

November 7, 2025

Kezar Life Sciences Announces Regulatory Update on Zetomipzomib Program in Autoimmune Hepatitis and Plans to Explore Strategic Alternatives

October 16, 2025

All Kezar Life Sciences, Inc. news →

Research Kezar Life Sciences, Inc.

Kezar Life Sciences, Inc. company profile

View the public company page for Kezar Life Sciences, Inc. on 6ix.

Kezar Life Sciences, Inc. news

Read company news and market updates connected to Kezar Life Sciences, Inc..

Kezar Life Sciences, Inc. investor events

Find investor webinars, events, and replay context for Kezar Life Sciences, Inc..